These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 9554180)

  • 1. National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. SCOPE Participant Group. Surveillance and Control of Pathogens of Epidemiologic.
    Pfaller MA; Jones RN; Messer SA; Edmond MB; Wenzel RP
    Diagn Microbiol Infect Dis; 1998 Feb; 30(2):121-9. PubMed ID: 9554180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National surveillance of nosocomial blood stream infection due to Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program.
    Pfaller MA; Jones RN; Messer SA; Edmond MB; Wenzel RP
    Diagn Microbiol Infect Dis; 1998 May; 31(1):327-32. PubMed ID: 9597393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International surveillance of bloodstream infections due to Candida species: frequency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada, and South America for the SENTRY Program. The SENTRY Participant Group.
    Pfaller MA; Jones RN; Doern GV; Sader HS; Hollis RJ; Messer SA
    J Clin Microbiol; 1998 Jul; 36(7):1886-9. PubMed ID: 9650930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International surveillance of blood stream infections due to Candida species in the European SENTRY Program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents. SENTRY Participant Group (Europe).
    Pfaller MA; Jones RN; Doern GV; Fluit AC; Verhoef J; Sader HS; Messer SA; Houston A; Coffman S; Hollis RJ
    Diagn Microbiol Infect Dis; 1999 Sep; 35(1):19-25. PubMed ID: 10529877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in species distribution and susceptibility to fluconazole among blood stream isolates of Candida species in the United States.
    Pfaller MA; Messer SA; Hollis RJ; Jones RN; Doern GV; Brandt ME; Hajjeh RA
    Diagn Microbiol Infect Dis; 1999 Apr; 33(4):217-22. PubMed ID: 10212747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. National epidemiology of mycoses survey: a multicenter study of strain variation and antifungal susceptibility among isolates of Candida species.
    Pfaller MA; Messer SA; Houston A; Rangel-Frausto MS; Wiblin T; Blumberg HM; Edwards JE; Jarvis W; Martin MA; Neu HC; Saiman L; Patterson JE; Dibb JC; Roldan CM; Rinaldi MG; Wenzel RP
    Diagn Microbiol Infect Dis; 1998 May; 31(1):289-96. PubMed ID: 9597389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and antifungal susceptibility of 442 Candida isolates from blood and other normally sterile sites: results of a 2-year (1996 to 1998) multicenter surveillance study in Quebec, Canada.
    St-Germain G; Laverdière M; Pelletier R; Bourgault AM; Libman M; Lemieux C; Noël G
    J Clin Microbiol; 2001 Mar; 39(3):949-53. PubMed ID: 11230409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Candida spp. in vitro susceptibility profile to four antifungal agents. Resistance surveillance study in Venezuelan strains.
    Panizo MM; Reviákina V; Dolande M; Selgrad S
    Med Mycol; 2009 Mar; 47(2):137-43. PubMed ID: 18651308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence, susceptibility profile for fluconazole and risk factors for candidemia in a tertiary care hospital in southern Brazil.
    Aquino VR; Lunardi LW; Goldani LZ; Barth AL
    Braz J Infect Dis; 2005 Oct; 9(5):411-8. PubMed ID: 16410893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Candida glabrata among Candida spp. from environmental health practitioners of a Brazilian Hospital.
    Savastano C; de Oliveira Silva E; Gonçalves LL; Nery JM; Silva NC; Dias AL
    Braz J Microbiol; 2016; 47(2):367-72. PubMed ID: 26991302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998.
    Pfaller MA; Jones RN; Doern GV; Sader HS; Messer SA; Houston A; Coffman S; Hollis RJ
    Antimicrob Agents Chemother; 2000 Mar; 44(3):747-51. PubMed ID: 10681349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.
    Xiao M; Fan X; Chen SC; Wang H; Sun ZY; Liao K; Chen SL; Yan Y; Kang M; Hu ZD; Chu YZ; Hu TS; Ni YX; Zou GL; Kong F; Xu YC
    J Antimicrob Chemother; 2015 Mar; 70(3):802-10. PubMed ID: 25473027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nosocomial bloodstream infections due to Candida spp. in the USA: species distribution, clinical features and antifungal susceptibilities.
    Wisplinghoff H; Ebbers J; Geurtz L; Stefanik D; Major Y; Edmond MB; Wenzel RP; Seifert H
    Int J Antimicrob Agents; 2014 Jan; 43(1):78-81. PubMed ID: 24182454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neonatal Candida infections and the antifungal susceptibilities of the related Candida species].
    Altuncu E; Bilgen H; Cerikçioğlu N; Ilki A; Ulger N; Bakır M; Akman I; Ozek E
    Mikrobiyol Bul; 2010 Oct; 44(4):593-603. PubMed ID: 21063972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibilities of Candida species to amphotericin B and fluconazole: the emergence of fluconazole resistance in Candida tropicalis.
    Yang YL; Ho YA; Cheng HH; Ho M; Lo HJ
    Infect Control Hosp Epidemiol; 2004 Jan; 25(1):60-4. PubMed ID: 14756222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Species distribution and antifungal susceptibility profile of Candida spp. bloodstream isolates from Latin American hospitals.
    Godoy P; Tiraboschi IN; Severo LC; Bustamante B; Calvo B; Almeida LP; da Matta DA; Colombo AL
    Mem Inst Oswaldo Cruz; 2003 Apr; 98(3):401-5. PubMed ID: 12886424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence of nosocomial candidemia at a teaching hospital in Taiwan from 1981 to 2000: increased susceptibility of Candida species to fluconazole.
    Hsueh PR; Teng LJ; Yang PC; Ho SW; Luh KT
    Microb Drug Resist; 2002; 8(4):311-9. PubMed ID: 12523628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital.
    Bedini A; Venturelli C; Mussini C; Guaraldi G; Codeluppi M; Borghi V; Rumpianesi F; Barchiesi F; Esposito R
    Clin Microbiol Infect; 2006 Jan; 12(1):75-80. PubMed ID: 16460550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The increased role of non-albicans species in candidaemia: results from a 3-year surveillance study.
    Tan TY; Tan AL; Tee NW; Ng LS; Chee CW
    Mycoses; 2010 Nov; 53(6):515-21. PubMed ID: 19619263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.